Coronavirus is making it tough to breathe, even for Indian pharmaceuticals
Posted by
www.biotecnika.org
Sun Pharmaceutical Industries' domestic sales were Rs 2,388 crore in
April-June compared with Rs 2,364 crore in the previous quarter.
Lupin's domestic business fell 6% from the same quarter last year.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/coronavirus-is-making-it-tough-to-breathe-even-for-indian-pharmaceuticals/articleshow/77454025.cms
Subscribe to:
Post Comments (Atom)
Post a Comment